NuCana (NCNA) Common Equity (2016 - 2025)

NuCana's (NCNA) quarterly Common Equity came in at $32.4 million in Q4 2025, up 323.44% year-on-year from $7.6 million in Q4 2024, and down 7.5% quarter-over-quarter from $35.0 million in Q3 2025.

NuCana (NCNA) Common Equity (2016 - 2025) Analysis & Trends

NuCana has disclosed Common Equity across 10 years of filings, most recently posting $32.4 million for Q4 2025.

  • Common Equity for Q4 2025 came in at $32.4 million, up 323.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.4 million (up 323.44% YoY), and the FY2025 annual result was $32.1 million, up 321.44% from the prior year.
  • Common Equity came in at $32.4 million for Q4 2025 at NuCana, down from $35.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $126.1 million in Q1 2021 to a low of $4.8 million in Q2 2024.
  • The 5-year median for Common Equity is $34.6 million (2023), against an average of $46.4 million.
  • Across the five-year window, Common Equity slumped 86.0% in 2024 and soared 519.25% in 2025, its largest moves.
  • NuCana's Common Equity stood at $88.4 million in 2021, then plunged by 48.89% to $45.2 million in 2022, then tumbled by 59.09% to $18.5 million in 2023, then slumped by 58.64% to $7.6 million in 2024, then soared by 323.44% to $32.4 million in 2025.
  • The last three Common Equity figures came in at $32.4 million (Q4 2025), $35.0 million (Q3 2025), and $9.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 35.63 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -1.42 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 13.21 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 NuCana 29.13 Bn 29.13 Bn - 32.36 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 32.36 Mn
Sep 30, 2025 34.98 Mn
Jun 30, 2025 9.85 Mn
Mar 31, 2025 5.26 Mn
Dec 31, 2024 7.64 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 4.80 Mn
Mar 31, 2024 12.85 Mn
Dec 31, 2023 18.48 Mn
Sep 30, 2023 27.58 Mn
Jun 30, 2023 34.26 Mn
Mar 31, 2023 38.59 Mn
Dec 31, 2022 45.16 Mn
Sep 30, 2022 62.10 Mn
Jun 30, 2022 70.57 Mn
Mar 31, 2022 78.79 Mn
Dec 31, 2021 88.36 Mn
Sep 30, 2021 106.77 Mn
Jun 30, 2021 117.68 Mn
Mar 31, 2021 126.11 Mn